Skip to main content

Table 1 Baseline characteristics of the study population

From: Assessment of the efficacy of hemodialysis on uric acid clearance in a sub-Saharan African population at the end stage kidney disease

Variables

Overall

Males

Females

N (%)

144 (100)

91 (63.2)

53 (36.8)

Mean age, year, (SD)

49.2 (14.1)

50 (14)

48 (15)

Age, min-max, year

15–74

22–74

15–74

Underlying nephropathy, n (%)

Hypertensive nephropathy

36 (25)

28 (19.4)

8 (5.6)

Unknown

27 (18.8)

13 (9)

14 (9.7)

Diabetic nephropathy

22 (15.3)

18 (12.5)

4 (2.8.)

Chronic glomerulonephritis

23 (16)

16 (11.1)

7 (4.9)

Chronic interstitial nephropathy

8 (5.6)

8 (5.6)

0 (0)

Gout nephropathy

7 (4.9)

0 (0)

7 (4.9)

Polycystic kidneys

7 (4.9)

1 (0.7)

6 (4.2)

Hypertension and diabetes

6 (4.2)

4 (2.8.)

2 (1.4)

HIV associated nephropathy

6 (4.2)

3 (2.1)

3 (2.1)

Hepatitis C nephropathy

1 (0.7)

1 (0.7)

0 (0)

Focal and segmental hyalinosis

1 (0.7)

0 (0)

1 (0.7)

Comorbidities, n (%)

Hypertension

128 (88.9)

84 (58.3)

44 (30.6)

Hyperuricemia

118 (81.9)

71 (40.9)

47 (32.6)

Excess weight

47 (32.6%)

30 (20.8)

17 (11.8)

Diabetes

33 (22.9)

23 (16)

10 (6.9)

Cardiopathies

24 (16.7)

17 (11.8)

7 (4.9)

Past history of cerebral stroke

12 (8.4)

9 (6.3)

3 (2.1)

Hepatitis C

18 (12.5)

12 (8.3)

6 (4.2)

HIV

7 (4.9)

3 (2.1)

4 (2.8)

Hepatitis B

3 (2.1)

3 (2.1)

0 (0)

Past history of gout

16 (11.1)

14 (9.7)

2 (1.4)

Tobacco consumption

4 (2.8)

4 (2.8)

0 (0)

Mean BMI, Kg/m2 (SD)

23.8 (3.6)

23.6 (2.7)

24.1 (4.9)

Residual diuresis, n (%)

< 100 mL/24 h

91 (63.2)

61 (42.4)

30 (20.8)

≥100 mL/24 h

53 (36.8)

30 (20.8)

23 (16)

Median time on HD replacement [Q25-Q75], year

3 [1; 6]

3 [1; 6]

2 [1; 5]

Interval between dialytic sessions, n (%)

< 3 days

24 (16.7)

15 (10.4%)

9 (6.3%)

≥3 days

120 (83.3)

76 (52.8%)

44 (30.6%)

Vascular access, n (%)

Fistula

124 (86.1)

79 (54.9)

45 (31.3)

Catheter

20 (13.9)

12 (8.3)

8 (5.6)

Size of the dialysis membrane, n (%)

FX10

105 (72.9)

73 (50.7)

32 (22.2)

FX8

37 (25.7)

17 (11.8)

20 (13.9)

FX5

2 (1.4)

1 (0.7)

1 (0.7)

Blood efflux, n (%),

< 300 ml/min

75 (52.1)

43 (29.9)

32 (22.2)

≥300 ml/min

69 (47.9)

48 (33.3)

21 (14.6)

Mean Kt/VUrea (SD)

1.3 (0.2)

1.2 (0.2)

1.5 (0.2)